Table 5.
Incidence of cyclosporine use and dose by renal pathology in allogeneic transplant recipients (n = 196)
| Pathology finding | n | Any CSA (n, %) | Median cumulative dose (mg) | Median dose per day (mg)a |
|---|---|---|---|---|
| Negative | 144 | 133 (92) | 4706 | 161 |
| TMA | 55 | 53 (96) | 13990 | 176 |
| Isolated | 40 | 38 (95) | 6975 | 174 |
Calculated as the cumulative dose divided by number of days alive post-transplant.